-
Neurofibromatosis type 1 patient attends Camp Fantastic for the first time
-
FDA grants breakthrough therapy designation for new CAR T-cell therapy
-
Clinical trial evaluates dual drug therapy for untreated follicular lymphoma
-
Researchers develop a new technique to increase quality of MRI images
-
New clinical trial tests CAR T-cell therapy for multiple myeloma
-
Today we #LightItRed for World #Lymphoma Awareness Day. Learn more about what our research scientists are working o… https://t.co/Hh6d4tfbBg
-
Meet Sue Scott! She will tell you her story with #cervicalcancer and the #clinicaltrial experience in this video… https://t.co/TLDnFyYEXY
-
Considering a #clinicaltrial? Tom's advice is to examine the risks and benefits. “There’s a lot of benefit to being… https://t.co/SGgstMsuyi
-
RT @NCIDrDougLowy: I'm pleased to share the inaugural post of a new blog for @theNCI grantees. Welcome to NCI Bottom Line: A Blog abou… https://t.co/zWHOtmhLhz
-
September is #ThyroidCancer Awareness Month. Dr. Zeiger is one of several of our scientists with a research focus o… https://t.co/xzlD6TUqjC
-
RT @NCICCR_MOS: Expanding #immunodeficient patients' options for life-saving bone marrow transplants is a major goal of… https://t.co/x2LgdMKTQi
-
The Cancer Data Science Laboratory @NCIEytanRuppin has several openings for Postdoctoral Fellow positions. Learn mo… https://t.co/4ksFhHQZJ4
